Evidence for decisions that cannot rely on assertion.

Organisations routinely invest millions in systems whose failure could create significant operational, regulatory or reputational consequences. AGDA™ exists to answer whether intervention remains possible before those consequences become irreversible.

View sample verdict How AGDA™ works

You are not buying activity. You are buying evidence.

The value of an Intervention Readiness assessment is determined by the significance of the decision it supports: deployment, high-risk system approval, regulatory scrutiny, board assurance, operational resilience or executive confidence.

  • Executive leadership

    Can we proceed with confidence?

    Evidence for deployment, approval and risk-acceptance decisions where assertion is not enough.

  • Risk leadership

    Can intervention still occur before harm becomes irreversible?

    A measured view of detection, escalation, decision and intervention capability against a reversibility window.

  • Board & audit committee

    What evidence supports this decision?

    A signed, independently verifiable AGDA™ verdict that can be relied on after the decision is made.

What every assessment produces.

A single structured output: an Intervention Readiness Verdict and Failure Exposure Report. Three audience layers, all bound to the same engine hash and attestation envelope.

  • Executive.

    CRO, board, audit committee

    Headline verdict, viability status, critical failure summary, regulatory exposure, priority actions. One-page decision frame.

  • Operational.

    Head of Operational Resilience, Head of Model Risk

    Plus temporal gating across eight gates with reasons, causal chain with timing, scenario impact, intervention chain, dimension findings.

  • Specialist.

    Intervention readiness owner, regulator liaison

    Plus irreversibility profile, failure profiles, single points of failure, framework pressure, regulatory mapping, JSON export, attestation envelope.

Intervention decision support.

A what-if console for the resilience function. Test whether proposed changes improve intervention timing without re-running the full assessment. Included with every tier.

Three levels of assurance. Priced by decision significance.

The commercial unit is evidence of Intervention Readiness. Price comes after the question answered, the evidence produced, and the decision being supported.

  1. Assurance level

    Pilot.

    Initial evidence for one consequential system.
    Question answered
    Can this system be stopped before harm becomes irreversible?
    Who it is for
    Executive, risk or board teams facing a material deployment, approval, remediation or oversight decision.
    Evidence produced
    Signed AGDA™ verdict, Failure Exposure Report, regulator bundle, attestation envelope, board evidence readout and intervention scenario support.
    Decision supported
    Deployment confidence, risk acceptance, remediation priority, board oversight and regulatory preparation.
    Why it matters
    Creates a defensible evidence standard before the organisation relies on assertion or expands assessment across more systems.
    Price
    • Short pilot · 1 system £95,000 €110,000 · $125,000
    • Structured pilot · 1 system £120,000 €140,000 · $155,000
    • Structured pilot · 2 systems £175,000 €205,000 · $225,000
    • Structured pilot · 3 systems £225,000 €265,000 · $290,000

    Assessment scope. Failure Exposure Report at all three audience layers, regulator bundle, attestation envelope, Labs Intervention Simulator access, board evidence readout, signed close-out memo.

  2. Assurance level

    Annual subscription.

    Standing evidence for recurring assurance decisions.
    Question answered
    Does Intervention Readiness remain evidenced as systems, dependence and operating conditions change?
    Who it is for
    Organisations that have completed a pilot and need recurring evidence for material systems.
    Evidence produced
    Two assessed systems per year, quarterly re-run rights, engine-hash pinning, updated verdicts and annual board evidence readout.
    Decision supported
    Continued deployment, control investment, oversight renewal, risk committee decisions and regulator-facing assurance.
    Why it matters
    Keeps the answer current as automation becomes more embedded and the cost of delayed intervention increases.
    Price
    • Annual subscription £180,000 / yr €210,000 / yr · $235,000 / yr
    • Equivalent quarterly £45,000 / qtr €52,500 / qtr · $58,750 / qtr

    Assessment scope. Standing Labs access, two assessed systems per year, engine-hash pinning, quarterly re-run rights on each system, annual board evidence readout.

  3. Assurance level

    Enterprise master.

    Group-level evidence across systems and entities.
    Question answered
    Can a complex organisation evidence intervention capability across the systems that matter most?
    Who it is for
    Multi-entity groups, regulated portfolios and organisations facing material automation exposure across several operating units.
    Evidence produced
    Portfolio-level Intervention Readiness verdicts, regulator-ready bundles, group CRO review, multi-entity reporting and designated AGDA™ operation.
    Decision supported
    Group assurance, regulatory engagement, critical deployment governance, resilience investment and board-level risk appetite.
    Why it matters
    Aligns evidence across entities so the board is not comparing local assertions against group-level exposure.
    Price
    • Enterprise assurance · custom-scoped £350,000+ / yr €410,000+ / yr · $450,000+ / yr

    Assessment scope. Up to 5 assessed systems per year, regulator-liaison support, quarterly portfolio review with group CRO, board evidence readouts, multi-entity invoicing, designated AGDA™ operator.

    Custom scope applies when assurance spans multiple legal entities, material system portfolios or sustained regulator engagement.

Add-ons.

Additional evidence, re-runs and support when the decision requires more coverage. Priced per unit. No volume discount on the first deal in a sector.

  • Additional assessed system, post-pilot £55,000 €65,000 · $72,000
  • Additional re-run, beyond quarterly included in Annual £20,000 €23,000 · $25,000
  • Additional named Labs operator £3,000 / term €3,500 / term · $4,000 / term
  • Board evidence readout, remote £12,000 €14,000 · $15,500
  • Board evidence readout, on-site £18,000 €21,000 · $23,000
  • Regulator bundle, post-engine-version change £6,000 €7,000 · $7,500

Assessment support.

  • Operator enablement, internal assurance team (up to 2 raters) £55,000 €64,000 · $70,000
  • Operator enablement, external assurance firm £85,000 €99,000 · $108,000
  • External assurance firm annual renewal £25,000 / yr €29,000 / yr · $32,000 / yr
  • Regulator-liaison support block £18,000 €21,000 · $23,000

Prices shown in GBP, EUR, and USD. All exclude VAT. Sector premium of 30 to 50 percent applies to clinical AI, medical devices, critical infrastructure, and defence. Other currencies on application.

What AGDA™ is not.

The category boundary matters. AGDA™ measures Intervention Readiness. It does not sell governance theatre under another name.

  • Not a governance framework.

    We do not score governance artefact completeness. We measure whether governance can actually intervene when required.

  • Not a compliance solution.

    Regulatory exposure is an output of the assessment. The category is Intervention Readiness, not clause adherence.

  • Not a risk score.

    AGDA™ produces a verdict on one question: can you stop it in time? It can inform a risk register. It does not substitute for one.

  • Not a monitoring tool.

    AGDA™ assesses intervention capability at a point in time. Runtime monitoring is a different product category.

Where the assessment belongs.

AGDA™ is priced against board assurance, model risk and operational resilience budgets. Not software procurement.

  • Board assurance.

    Where the question is whether oversight can actually intervene, not whether oversight has been described.

  • Model risk and operational resilience.

    Where the system is material, automated, and capable of creating harm faster than authority can move.

  • Regulatory engagement preparation.

    Where the organisation needs verifiable evidence of Intervention Readiness, not certification or regulatory approval.

AGDA™ at £95,000 for a pilot or £180,000 per year for an annual subscription turns that budget into a signed verdict on one question: can the organisation intervene before harm becomes irreversible?

Nominate a system. Measure whether it can be stopped in time.

The pilot is sized around one consequential system and one Intervention Readiness question. Review the sample verdict first if you want to see the evidence standard.

View sample verdict Book a conversation